It is demonstrated that miR-223-3p attenuates LPS-Induced SLMD by inhibiting the NLRP3 inflammasome and cardiomyocyte pyroptosis and upon treatment with NLRP3 siRNA or a GSDMD-targeting pyroptosis inhibitor disulfiram, miR-223-3p failed to exert additional protective effects against SLMD.
Sepsis-induced cardiac dysfunction is a primary contributor to mortality, and microRNAs (miRNAs) are recognized as crucial mediators in sepsis pathogenesis. This study aims to identify the key regulatory miRNAs involved in cardiac dysfunction stemming from sepsis. We developed a rat model of sepsis using cecal ligation...
Yike Zhu, Jinjun Wang, Lingwen Zhang et al.· Journal of Immunology· 0 citations
Background Sepsis is frequently complicated by systemic inflammatory injury and cardiac dysfunction, which serve as risk factors of adverse clinical outcomes and increased mortality risk. To clarify the function of miR-130a-3p in sepsis diagnosis and its regulatory role in sepsis-induced inflammatory injury and cardiac...
Jin-Yu Liu, Xiaowei Yuan, Wei Chen et al.· Clinical and applied thrombo...· 0 citations
BACKGROUND
Septic cardiomyopathy (SCM) is a severe manifestation of sepsis characterized by myocardial dysfunction and systemic inflammation. The NLRP3 inflammasome-driven pyroptosis plays a pivotal role in SCM pathogenesis. This study aimed to elucidate the upstream molecular regulators of pyroptosis in SCM and invest...
Wei Dong, Wen Liu, Yan Yin et al.· Molecular Immunology· 0 citations
A maladaptive NF-κB/miR-378c/IRG1 axis in septic AKI is defined, where inflammation-induced miR-378c silences a key metabolic protector in tubular cells and represents a promising therapeutic strategy to preserve renal function during sepsis.
Lulu Zhou, Xiang Zhou, Hong-Mei Deng et al.· Renal Replacement Therapy· 0 citations
Myocardial ischemia-reperfusion (I/R) injury remains a leading cause of cardiac dysfunction and mortality worldwide. Serine/arginine-Rich Protein Kinase 3 (SRPK3) is highly expressed in cardiac muscle, yet its specific pathological role in I/R injury has not been fully characterized. In this study, we utilized cardiac-...
Yun Xing, Saiyang Xie, Nan Zhao et al.· Acta Pharmacologica Sinica· 0 citations
This article examined the effect of DLX6-AS1 on ischemia perfusion-induced myocardial injury caused by necroptosis and the underlying potential mechanism and identified the possible mechanism by overexpressing and inhibiting DLX6-AS1 expression.
Yan-Ping Su, Li-Ting Mu, Lei Wang et al.· Scientific Reports· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.